Lai Wang Sells 5,000 Shares of Beigene, Ltd. (NASDAQ:ONC) Stock

Beigene, Ltd. (NASDAQ:ONC) insider Lai Wang sold 5,000 shares of the business’s stock in a transaction that occurred on Friday, February 21st. The stock was sold at an average price of $257.23, for a total transaction of $1,286,150.00. Following the completion of the transaction, the insider now owns 920,920 shares in the company, valued at $236,888,251.60. This trade represents a 0.54 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.

Beigene Price Performance

Shares of NASDAQ ONC opened at $259.00 on Thursday. The firm has a market cap of $25.35 billion, a P/E ratio of -31.43, a PEG ratio of 7.73 and a beta of 0.63. The company has a quick ratio of 1.72, a current ratio of 1.93 and a debt-to-equity ratio of 0.05. Beigene, Ltd. has a twelve month low of $126.97 and a twelve month high of $268.45.

Beigene Company Profile

BeiGene Ltd. Is a global oncology company, which engages in providing pharmaceutical products. Its medicines include BRUKINSA, TEVIMBRA, and PARTRUVIX. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in George Town, KY.